Study on a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Compared to a Meningococcal Reference Vaccine, and When Given Alone or With Two Other Vaccines in Healthy Adolescents
Condition: Meningococcal Infection (Healthy Volunteers) Interventions: Biological: Meningococcal Polysaccharide (Serogroups A, C, Y, and W) Tetanus Toxoid Conjugate Vaccine MenACYW conjugate vaccine; Biological: Meningococcal group A, C, W-135, and Y conjugate vaccine; Biological: Human Papillomavirus 9-valent Vaccine 9vHPV; Biological: Tetanus Toxoid, Red uced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed Combined with Inactivated Poliomyelitis Vaccine Tdap-IPV Sponsor: Sanofi Pasteur, a Sanofi Company Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 28, 2020 Category: Research Source Type: clinical trials